1-3 of 3
Johannes Brandstetter, PhD
Close
Sort by
Journal Articles

Design Of a Most Efficient Inhibitor Of TFPI By Molecular Fusion Of Two Inhibitory Peptides

Michael Dockal, PhD, Rudolf Hartmann, PhD, Thomas Polakowski, PhD, Johannes Brandstetter, PhD, Willibald Kammlander, Erwin Panholzer, Christoph Redl, Frank Osterkamp, PhD, Jan Rosing, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2013) 122 (21): 3564.
https://doi.org/10.1182/blood.V122.21.3564.3564
Published: 2013
Journal Articles

Crystal Structure Of Tissue Factor Pathway Inhibitor (TFPI) Kunitz Domain 1 and 2 In Complex With An Inhibitory Cyclic Peptide,

Michael Dockal, PhD, Rudolf Hartmann, PhD, Markus Fries, PhD, Katerina Prohaska, Robert Pachlinger, PhD, Thomas Polakowski, PhD, Johannes Brandstetter, PhD, Jan Rosing, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2013) 122 (21): 453.
https://doi.org/10.1182/blood.V122.21.453.453
Published: 2013
Journal Articles

Peptides Binding to Kunitz Domain 1 of Tissue Factor Pathway Inhibitor (TFPI) Inhibit All Functions of TFPI and Improve Thrombin Generation of Hemophilia Plasma

Michael Dockal, PhD, Johannes Brandstetter, PhD, Martin Ludwiczek, Georg Kontaxis, PhD, Markus Fries, PhD, M C L G D Thomassen, PhD, A Heinzmann, PhD, Hartmut J. Ehrlich, MD, Katerina Prohaska, Rudolf Hartmann, PhD, Jan Rosing, Professor, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2011) 118 (21): 2245.
https://doi.org/10.1182/blood.V118.21.2245.2245
Published: 2011